Dental Hygiene: Page 500

FDA warns Dentsply about advertising violations

By Rob Goszkowski

In what is being characterized as "serious" violations, the U.S. Food and Drug Administration has issued a warning letter to Dentsply for misbranding its localized anesthetic Oraqix in a journal ad and professional mailers.

January 18, 2011

Do oxalates ease dentin hypersensitivity?

By Rob Goszkowski

A systematic review of oxalate treatments for dentin hypersensitivity suggests that oxalates were no more effective than a placebo, and the review authors take much of the previous research to task for "lax methods" used in assessing efficacy.

January 18, 2011

Clinical drug trial addresses xerostomia in cancer patients

By DrBicuspid.com staff writers

Acacia Pharma has initiated a phase I clinical study of APD515, an oromucosal formulation of an existing drug, for use in the treatment of xerostomia in advanced cancer patients.

January 17, 2011

Oasis Diagnostics to market dry mouth product

By DrBicuspid.com staff writers

Amarillo Biosciences and Oasis Diagnostics have entered into an agreement for Oasis to exclusively market Maxisal, Amarillo Biosciences' dietary supplement for enhancing salivary function, promoting oral comfort, and relieving dry mouth, in North, Central, and South America; China; and Taiwan.

January 17, 2011

Dental implant firm announces IPO terms

By DrBicuspid.com staff writers

BioHorizons, a manufacturer of dental implants, said it expects to raise $90 million by offering 5.6 million shares at a price range of $15 to $17 in its initial public offering (IPO).

January 17, 2011

4th Merck osteonecrosis trial begins

By DrBicuspid.com staff writers

Merck will again "vigorously defend itself" against allegations that its Fosamax bisphosphonate drug caused dental and jaw-related problems in a jury trial that began January 18 in New Jersey.

January 17, 2011

Deconstructing the arguments against BPA

By Rod Franklin

The case against bisphenol A (BPA) as an estrogen-mimetic toxin is weakening, according to a presentation last week at the Rocky Mountain Dental Convention in Denver.

January 16, 2011

Cancer patient loses case against tobacco firm

By DrBicuspid.com staff writers

A Saudi Arabian court dismissed a lawsuit filed by a man with throat cancer against a tobacco company because there was no clear-cut evidence that his cancer was caused by smoking, according to a report by Emirates News.

January 13, 2011

IMRT improves outcomes in head/neck cancer patients

By DrBicuspid.com staff writers

Patients with pharyngeal cancer had better salivary function, less xerostomia, and improved quality of life when treated withintensity-modulated radiotherapy (IMRT) rather than conventional radiotherapy, according to a new study in Lancet Oncology.

January 13, 2011

AAPHD applauds new fluoride recommendations

By DrBicuspid.com staff writers

The American Association of Public Health Dentistry (AAPHD) supports the recent recommendation by the U.S. Department of Health and Human Services and the Environmental Protection Agency to set the optimal level for fluoride in drinking water at 0.7 parts per million.

January 13, 2011

U.S. marshals seize dental products from Fla. firm

By DrBicuspid.com staff writers

The U.S. Food and Drug Administration is advising healthcare professionals to discontinue using Rite-Dent products after U.S. marshals seized all dental products from the company's Florida facility in the wake of a series of manufacturing violations.

January 12, 2011

Argentine firm to store dental pulp stem cells

By DrBicuspid.com staff writers

Biocordcell Argentina, a Cord Blood America company, has launched a program to store dental pulp stem cells, the first stem cell storage bank in Argentina to offer this service.

January 12, 2011

Previous Page

Page 500 of 585

Next Page